Research programme: 2-acylglycerol-O-acyltransferase inhibitors - Venenum Biodesign
Alternative Names: Research programme: MGAT2 inhibitors - Venenum Biodesign; Research programme: monoacylglycerol acyltransferaseare-2 inhibitors - Venenum BiodesignLatest Information Update: 02 Dec 2022
Price :
$50 *
At a glance
- Originator VENENUM Biodesign
- Class Hepatoprotectants; Small molecules
- Mechanism of Action 2 acylglycerol O acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
Most Recent Events
- 28 Nov 2022 Early research in Non-alcoholic fatty liver disease in USA (unspecified route) (Venenum Biodesign pipeline, November 2022)
- 28 Nov 2022 Early research in Non-alcoholic steatohepatitis in USA (unspecified route) (Venenum Biodesign pipeline, November 2022)
- 28 Nov 2022 Pharmacodynamics data from a preclinical trial in Non-alcoholic steatohepatitis released by Venenum Biodesign